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Abstract
Introduction: Congenital obstructive megaureter may be treated 
with endoscopic balloon dilatation, particularly in children un-
der one year of age. We report our experience over a six year 
period.
Methods: All patients with diagnosis of primary obstructive me-
gaureter treated with endoscopic balloon dilatation from 2009 
to 2014 (6 years) were included. The diagnosis of primary obs-
tructive megaureter was based on dilatation of the distal ureter 
greater than 7 mm, obstructive curve on MAG-3 diuretic reno-
gram and absence of vesicoureteral reflux. After diagnosis, 
conservative management was maintained with antibiotic pro-
phylaxis in all patients. The indications for surgery were a com-
bination of clinical, ultrasonographic and renographic findings. 
Under general anesthesia and after retrograde ureteropielogra-
phy, high pressure balloon dilation of the ureterovesical junction 
was performed under direct and fluoroscopic vision until the 
disappearance of the narrowed ring. A double-J catheter was 
positioned. Follow-up was performed with ultrasonography and 
diuretic renogram. The success of the intervention was defined 
by improvement of hydroureteronephrosis (at least 2 grades).
Results: A total of nine patients underwent this procedure on 
a single ureter, two girls and seven boys, with a mean age of 
7.6 months (range 1-14) at the intervention. Five were left sided 
and four were right sided. All patients had prenatal diagnosis of 
hydroureteronephrosis. No patients were lost to follow-up (ave-
rage 46.7 months). They all had hydroureteronephrosis greater 
than grade 3 and preoperative MAG-3 diuretic renogram was 
obstructive in all cases.  Mean differential function of the af-
fected kidney was 46.2% (range 40-53%). The main indication 
for surgical treatment was progressive hydroureteronephrosis. 
All patients were treated endoscopically with no intraoperative 
complications. Ultrasound showed improvement of the hydrou-
reteronephrosis in six patients (66.7%). Three patients were rei-
mplanted (33.3%). The mean differential renal function after the 
procedure was 47.4% (range 41-53%). At the latest follow-up 
assessment, all patients remained asymptomatic.
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Resumo
Introdução: O megauretero obstrutivo congénito pode ser tra-
tado por dilatação endoscópica com balão, especialmente nas 
crianças com menos de um ano de idade. Este trabalho revela a 
nossa experiência num período de seis anos.
Métodos: Todos os doentes com o diagnóstico de megauretero 
obstrutivo congénito submetidos a dilatação endoscópica com 
balão foram incluídos, no período de tempo compreendido en-
tre 2009 e 2014 (seis anos). O diagnóstico baseou-se na iden-
tificação de dilatação do uretero distal superior a 7 mm, padrão 
obstrutivo no renograma MAG-3 e ausência de refluxo vesico-u-
reteral. Após o diagnóstico, adoptou-se uma atitude conservado-
ra com início de profilaxia antibiótica e vigilância ecográfica em 
todos os doentes. A indicação cirúrgica resultou de um conjunto 
de achados clínicos, ecográficos e renográficos. Sob aneste-
sia geral, e após pielografia retrógrada, foi realizada dilatação 
endoscópica da junção uretero-vesical sob visão directa e con-
trolo fluoroscópico até ao desaparecimento do anel estenótico, 
colocando-se no final um stent duplo J. O seguimento foi feito 
com controlo ecográfico e renograma. O sucesso da intervenção 
cirúrgica foi definido como uma melhoria no grau de hidrourete-
ronefrose (pelo menos 2 graus).
Resultados: No total, 9 doentes foram intervencionados num só 
ureter, duas meninas e sete meninos, com idade média de 7,6 me-
ses (entre 1-14) na data da cirurgia. Cinco foram no lado esquer-
do e quatro no lado direito. Todos os doentes tinham diagnóstico 
pré-natal de hidroureteronefrose. Nenhum doente foi perdido no 
seguimento (média 46,7 meses). Todos tinham hidroureteronefro-
se de grau superior ou igual a 3 e padrão obstrutivo no renograma 
MAG-3. A função relativa média do rim homolateral foi 46,2% (en-
tre 40-53%). A principal indicação cirúrgica foi o agravamento da 
hidroureteronefrose durante a vigilância ecográfica. Não existiram 
complicações intra-operatórias. A ecografia mostrou melhoria da 
hidroureteronefrose em seis doentes (66,7%). Três doentes foram 
re-implantados (33,3%) A função relativa média após a cirurgia foi 
47,4% (entre 41-53%). Na consulta de seguimento mais recente, 
todos os doentes estavam assintomáticos.
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Conclusion: Endoscopic balloon dilatation is a useful option in 
the management of primary obstructive megaureter requiring 
surgical intervention and may be considered first line treatment 
in small children.
Keywords: Child; Constriction, Pathologic; Dilatation; Endos-
copy; Hydronephrosis; Ureter/abnormalities; Ureteral Obs-
truction.
Introduction
Megaureter is not a diagnosis but a descriptive term for a dila-
ted ureter.1 A retrovesical ureteric diameter greater than 7 mm 
from 30 week’s gestation onwards is abnormal and should be 
investigated postnatally.2  
Smith classified megaureters into four categories: obstruc-
ted, refluxing, refluxing with obstruction and non-refluxing/
non-obstructed. These were later subdivided by King into pri-
mary and secondary.2
Primary obstructive megaureter (POM) is most commonly 
caused by a distal adynamic ureteral segment.  A few histopa-
thologic characteristics of the adynamic segment have been 
described such as abnormal neuromodulation, abnormal 
collagen deposition and abnormalities in the interstitial cells of 
Cajal.3 The timing of smooth muscle differentiation in the distal 
ureter is unknown but may be the key to explain pathogenesis 
of primary (or congenital) megaureter.
The process whereby the circular muscle pattern, which is 
typical of the fetal ureter, changes progressively into double 
muscle layers on the full term infant, may last up to two years,2 
and may explain why this condition resolves spontaneously 
in approximately 80% of those patients diagnosed prenatally 
and that is why conservative management is safe initially.4 
Surgical management is indicated when initial differential re-
nal function (DRF) is less than 40% and when conservative ma-
nagement fails.2 Traditionally, the surgical management of POM 
has been via ureteral reimplantation with or without ureteral re-
modeling. However, in newborns and children under one year of 
age this technique is very difficult and has a high complication 
rate.  Temporary cutaneous diversion may be beneficial in this 
cases but it will require two or more procedures for correction.  
With advent of minimally invasive surgery, in 1998, Angulo 
et al published the first report of endoscopic balloon dilatation 
for POM in children and, since then, several publications have 
shown that the procedure is feasible, safe and less invasive in 
very young patients.5
This study assesses the long-term effectiveness of endos-
copic balloon dilatation in a case-series of six years, in order 
to evaluate if it can be considered as an alternative to ureteral 
reimplantation in small children with POM. 
Conclusão: A dilatação endoscópica com balão é uma opção na 
abordagem do megauretero obstrutivo primário com indicação 
operatória e pode ser considerado como tratamento de primeira 
linha nas crianças com menos de um ano de idade.
Palavras-chave: Criança; Constrição Patológica; Dilatação; En-
doscopia; Hidronefrose; Obstrução Ureteral; Ureter/anomalias 
congénitas.
Methods
All patients with diagnosis of POM treated with endoscopic 
balloon dilatation from 2009 to 2014 were included. Data from 
clinical records was retrieved.
The diagnosis of POM was based on the following parame-
ters: dilatation of the distal ureter greater than 7 mm, obstruc-
tive curve on MAG-3 diuretic renogram and absence of vesi-
coureteral reflux (VUR). Ultrasound was employed to measure 
the diameter of renal pelvis, distal ureter and the characteris-
tics of renal parenchyma. The degree of HUN was defined in 
accordance with guidelines of the Society for Fetal Urology.6-8 
Voiding cystourethrogram (VCUG) was performed to rule out 
VUR. On MAG-3 diuretic renogram, obstruction was defined 
as persistence of more than 50% of the tracer in the renal pel-
vis 20 minutes after diuretic administration.
After the initial diagnosis, conservative management was 
maintained with antibiotic prophylaxis (oral trimethoprim 1% 
0.1 mL/kg, once a day) in all patients. The indications for sur-
gery were a combination of clinical, ultrasonographic and 
renographic findings with at least one of the following condi-
tions: initial DRF < 40% with an obstructive excretion pattern 
on renogram MAG-3, progressive HUN or febrile urinary tract 
infection (UTI) (Table 1).
Under general anesthesia, cystoscopy was performed with 
a Wolf® 9Fr pediatric cystoscope (Knittlingen, Germany) with 
a 5Fr working channel. The ureterovesical junction was pas-
sed with a flexible guidewire (0.014 mm Terumo®) introduced 
up to the renal pelvis which was then filled with radiologic con-
trast (Fig. 1A), confirming the diagnosis of megaureter and the 
defining anatomy. A Biosensors Powerline® dilating balloon 
catheter (4 mm diameter and 30 mm length) was insufflated 
to 12 or 14 atmospheres until the stenotic ring was no longer 
present (with 3 to 6 minutes of waiting time). The stenotic ring 
was always visible before dilatation. Then, distal ureterogra-
phy was performed, confirming dilatation of the stenotic seg-
ment and a 4-4.8Fr 10-14 cm double-J stent was left in place 
(Fig. 1B). The bladder catheter was withdrawn after 24 hours 
of surgery and the patient was discharged after 24-48 hours, 
depending on haematuria. The double-J stent was removed 





Follow-up included renal ultrasound at one, three, nine and 
twelve months and annually thereafter; MAG-3 diuretic reno-
gram at six months, two and five years. VCUG was not per-
formed routinely. Antibiotic prophylaxis was maintained until 
stent was removed.
The success of the intervention was defined by improve-
ment of HUN (at least 2 grades). Success rate was calculated 
with 95% confidence interval (95% CI) using openEPI.9,10 Data 
on upper urinary tract infections and further surgical interven-
tions were collected. 
Results 
Out of 110 cases of diagnosed megaureters on that period, 
a total of nine patients underwent this procedure on a single 
ureter, two girls and seven boys, with a mean age of 7.6 mon-
ths (range 1-14) at the intervention. Five were left sided and 
four were right sided. All patients had prenatal diagnosis of 
HUN. No patients were lost to follow-up (average 46.7 months; 
standard deviation 21.2) (Table 1).
They all had HUN greater than grade 3. VCUG showed exis-
tence of Hutch’s diverticulum in two patients and none had VUR. 
Preoperative diuretic renogram was obstructive in all patients in 
whom it was performed (patients 2, 3, 4, 7 and 9). Mean differen-
tial function of the affected kidney was 46.2% (range 40-53%). 
The indication for surgical treatment was progressive HUN 
in eight cases and deterioration of renal function (DRF less 
than 40%) in one case (Table 1).
All nine patients were treated endoscopically with no in-
traoperative complications. There was one case of stent mi-
gration to the distal ureter that was removed endoscopically.
Ultrasound showed improvement of the HUN in six patients 
(Fig. 2). The success rate was 66.67% (95% CI) (Table 1).
Three patients were reimplanted (one Cohen and two Poli-
tano-Leadbetter neoureterocistostomy). Patients 3 and 6 were 
reimplanted because of recurrent urinary infections, two and 
six months after endoscopic dilatation, respectively. One pa-
tient was reimplanted twenty-one months after endoscopic 
balloon dilatation because of worsening of HUN with persis-
tence of the obstructed pattern in a diuretic renogram.
The mean DRF after the procedure was 47.4% (range 41-
53%). The mean follow-up was 46.7 months (range 12-72) 
(Table 1).
At the most recent follow-up assessment, all patients re-
mained asymptomatic. The two patients with shorter follow-up 
were assessed at about two years of age. Both had great im-
provement of HUN without obstructive pattern at the postope-
rative MAG-3 renogram.
Discussion
In this case-series, the primary success rate was 66.7%. In 
three cases (33.3%) the ureter was reimplanted. The secon-
dary success rate (after reimplantation) was 100%. These re-
sults are similar to those previously published.
In 1998 Angulo et al and in 2007 Angerri et al described the 
first POM treatment with endoscopic balloon dilatation, which 
Table 1: Patients characteristics and results
Patient 
number
















1 1 prenatal 3 − increasing HUN 0 49 no 72
2 14 prenatal 3 49 increasing HUN 0 49 no 60
3 13 prenatal 3 40 DRF < 40 3 45 yes - recurrent febrile UTI 60
4 2 prenatal 4 44 increasing HUN 1 44 no 60
5 9 prenatal 3 − increasing HUN 0 49 no 48
6 1 prenatal 3 − increasing HUN 3 −
yes - persistent 
HUN + febrile 
UTI
48
7 7 prenatal 4 45 increasing HUN 4 49
yes - increa-
sing HUN 48
8 12 prenatal 3 − increasing HUN 0 41 no 12
9 9 prenatal 4 53 increasing HUN 2 53 no 12
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was believed to be a definitive, safe and less invasive treat-
ment that avoids unnecessary open surgery.5  A small number 
of publications have reported short series with good results in 
the short and medium-term. García-Aparicio et al11 presented 
a series of thirteen patients with postoperative improvement of 
HUN in 84.6% (eleven cases) and need for reimplantation in 
23% (three cases).  Carroll et al3 presented a series of thirty-o-
ne patients with improvement of HUN in 48.4% (fifteen cases) 
and reimplantation in 35.4% (eleven cases).
Historically, the surgical management of POM has been ba-
sed on ureteral reimplantation with or without ureteric remode-
ling, with a reported success rate of 90-96%.5 However, urete-
ric reimplantation in infants less than one-year of age may be 
challenging due to the discrepancy between the grossly dilated 
ureter and the small infantile bladder and the concern regar-
ding possible iatrogenic bladder dysfunction, such as VUR.2
Therefore, some authors consider alternative temporizing 
or permanent interventions avoiding reimplantation in infancy. 
In the era of minimally invasive surgery, endoscopic mana-
gement of POM offers a less invasive option for treatment. Fur-
thermore, should an endoscopic approach fail, reimplantation 
surgery can still be performed.10
The youngest patient in the series of Angerri et al was twelve 
months, in Garcia-Aparicio et al was four months, in Carroll 
et al was two months and in Bujon et al was one month. In 
the present series the youngest patient subject to intervention 
was one month old.3-5,11 
The stents were left for more time than the average mentio-
ned on literature (2 months) because of the need of general 
anesthesia and lack of operating room availability.
Virtually no morbidity was detected, with only one case of 
stent migration without clinical implications. 
Figure 1: Cystoscopy. A: Contrast injection B: stent positioning.








This study has a small number of cases and short follow-
-up time which limits conclusions, however the results show 
that endoscopic balloon dilatation is a useful option in the 
management of POM requiring surgical intervention, reducing 
morbidity associated with open surgery without sacrificing ef-
ficacy. 
Conclusion
This study shows that endoscopic balloon dilatation of POM 
is a safe, feasible and less invasive procedure with few pos-
t-operative complications  and may be considered first line 
treatment in the management of POM in small children.   ●
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